Skip to content
10-K

Annual Report

Molecular Templates, Inc.

0001558370-24-004332

← back to feed
Filed
Mar 29, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 25, 2024 5.37M sh
Shares Diluted FY 2023 · Dec 31, 2023 4.5M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 3.76M sh
Capex FY 2023 · Dec 31, 2023 $200K
Capex FY 2023 · Dec 31, 2022 $3.2M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$41.82M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$89.02M
Cash And Equivalents FY 2023 · Dec 31, 2023 $11.52M
Cash And Equivalents FY 2023 · Dec 31, 2022 $32.19M
Stockholders Equity FY 2023 · Dec 31, 2023 $4.21M
Stockholders Equity FY 2023 · Dec 31, 2022 −$15.13M
Stockholders Equity FY 2023 · Dec 31, 2021 $65.66M
Current Liabilities FY 2023 · Dec 31, 2023 $17.32M
Current Liabilities FY 2023 · Dec 31, 2022 $57.08M
Total Liabilities FY 2023 · Dec 31, 2023 $31.17M
Total Liabilities FY 2023 · Dec 31, 2022 $112.68M
Current Assets FY 2023 · Dec 31, 2023 $16.77M
Current Assets FY 2023 · Dec 31, 2022 $68.3M
Total Assets FY 2023 · Dec 31, 2023 $35.38M
Total Assets FY 2023 · Dec 31, 2022 $97.55M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.80
Eps Diluted restated FY 2023 · Dec 31, 2022 −$24.69
Eps Basic FY 2023 · Dec 31, 2023 −$1.80
Eps Basic restated FY 2023 · Dec 31, 2022 −$24.69
Sga Expense FY 2023 · Dec 31, 2023 $18.9M
Sga Expense FY 2023 · Dec 31, 2022 $26.2M
Rd Expense FY 2023 · Dec 31, 2023 $48.88M
Rd Expense FY 2023 · Dec 31, 2022 $82.43M
Net Income FY 2023 · Dec 31, 2023 −$8.12M
Net Income FY 2023 · Dec 31, 2022 −$92.72M
Operating Income FY 2023 · Dec 31, 2023 −$10.47M
Operating Income FY 2023 · Dec 31, 2022 −$88.87M
Long Term Debt FY 2023 · Dec 31, 2022 $36.17M